Jounce Therapeutics, Inc.
JNCEDelisted May 4, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001640455
Jounce Therapeutics, Inc. was delisted on May 4, 2023; its insiders filed their last Form 4 on May 5, 2023; 84 institutions reported holding it in 13F filings for Q1 2023, worth $64.1M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Jounce Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 130 | 1 | 115 | −14 |
| Shares | 36.0M | 35.7K | 36.4M | +438.6K (+1.2%) |
| Value | $244.8M | $243.0K | $270.6M | +$26.1M (+10.7%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (11)
Institutions that held Jounce Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 2,000,000 | $14.9M | 1.07% |
| RTW Investments, LP | 1,396,203 | $10.4M | 0.16% |
| Jasper Ridge Partners, L.P. | 50,858 | $378.0K | 0.02% |
| Franklin Resources Inc | 39,321 | $292.0K | 0.00% |
| SG Americas Securities, LLC | 23,393 | $174.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 19,784 | $147.0K | 0.00% |
| MetLife Investment Management | 12,647 | $94.0K | 0.00% |
| Lazard Asset Management LLC | 12,095 | $89.0K | 0.00% |
| Algert Global LLC | 10,200 | $76.0K | 0.01% |
| Metropolitan Life Insurance Co | 9,568 | $71.1K | 0.00% |
| Koshinski Asset Management, Inc. | 300 | $2.23K | 0.00% |
Sold out (25)
Institutions that held Jounce Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (1)
Institutions that held Jounce Therapeutics, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| QS Investors, LLC | 35,700 | $243.0K |